The activation of inflammasome, especially NLRP3, in chronically inflamed patients, such as those with type 2 diabetes, is associated with the production of pro-inflammatory cytokines (e.g., IL-1β and IL-18)39. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.